Abstract Purpose of Review Long-COVID is a novel condition emerging from the COVID-19
pandemic. Long-COVID is characterized by symptoms commonly seen in autonomic …

As global numbers of COVID-19 grow, chronic neurological symptoms, including those of
autonomic dysfunction, are being reported with increasing frequency. Mounting evidence …

Introduction. The severity and prevalence of Post-Acute COVID-19 Sequela (PACS) or long-
COVID syndrome (long COVID) should not be a surprise. Long-COVID symptoms may be …

Background The association between autonomic dysfunction and long‐COVID syndrome is
established. However, the prevalence and patterns of symptoms of dysautonomia in long …

Long-COVID syndrome is characterized by fatigue, orthostatic intolerance, tachycardia, pain,
memory difficulties, and brain fog, which may be associated with autonomic nervous system …

Patients with long COVID suffer from many neurological manifestations that persist for 3
months following infection by SARS-CoV-2. Autonomic dysfunction (AD) or dysautonomia is …

Purpose Post-COVID-19 syndrome is a poorly understood aspect of the current pandemic,
with clinical features that overlap with symptoms of autonomic/small fiber dysfunction. An …

A significant proportion of patients infected from SARS-CoV-2 experience new, recurring, or
ongoing symptoms usually 3 months after infection that may last for weeks or months and …

Introduction On March 11, 2020, the World Health Organization sounded the COVID-19
pandemic alarm. While efforts in the first few months focused on reducing the mortality of …

Background Autonomic dysfunction is a known complication of post-acute sequelae of
SARS-CoV-2 (PASC)/long COVID, however prevalence and severity are unknown …